Anthony Harrelson of North Caroline acknowledges that a workable HIV vaccine may still be a ways off, but his company, White Oak Industries, has been making strides towards that goal for the past several years. Dr. Harrelson is White Oak’s founder and CEO, and he says that his team has been closer than ever to the breakthrough they need to finally realize his project’s potential. Dr. Harrelson started the viral vaccine project several years ago with the help of only a few investors and a general idea of how his treatment would work. A Doctor of Microbiology, Harrelson sought to combat serious viral infections by reprogramming the body’s immune system slightly to attack infected cells and virus particles only.
Anthony Harrelson of North Carolina isn’t shy about his end goal: he wants to be the first in the world to develop a useable HIV vaccine. His team is at work on a vaccine for a particular type of HIV. Of the many strains of the virus, Dr. Harrelson’s team will try to create a vaccine that affects the most Americans in the world. Harrelson wanted to start with a product that would be highly sought-after in his own country before he went abroad. His team has found a way to use the body’s dendritic cells to find the viruses everywhere throughout a patient’s body. The most dangerous viruses, including HIV, hide themselves within the body of a patient, masking their presence from the body’s immune system whose job it is to hunt down all dangerous foreign particles.
Anthony Harrelson of North Carolina operates his company, White Oak Industries from Archdale. White Oak Industries is a prominent biopharmaceutical company that has been working on developing new immunotherapeutic treatments for highly contagious infectious diseases. Viruses such as Ebola and HIV have been running rampant around the world, from Africa to the United States. Dr. Harrelson, together with his research and development team at White Oak, hopes to end the suffering of the millions of people affected by these diseases once and for all.
Anthony Harrelson North Carolina has focused his company’s research and development efforts on immunotherapy because he believes that these kinds of drugs have the greatest potential to stop the spread of infectious diseases. His team at White Oak Industries has been working in the clinical-stage biotechnology sector to create vaccines for viruses like HIV using White Oak’s proprietary DNA platform technology. Dr. Harrelson hopes to meet a huge medical need and create a huge commercial opportunity. Dr. Harrelson’s long-term goal is to create therapies for some of the most dangerous infectious diseases afflicting the most people in the world at the moment.
Anthony Harrelson of North Carolina has been working hard to develop vaccines that will fight and prevent individuals from being infected in the first place. White Oak Industries will continue its work on finding ways to use immunotherapy to fight infectious diseases until it has a definitive treatment that truly works. Harrelson is confident that his research and development team will create a usable product soon to help the millions of people suffering from HIV infection and more.